Lintlha tsa bohlokoa bakeng sa batsoali le bahlokomeli:

• Katleho: Karabelo ea 'mele ea ho itšireletsa mafung ea bana ba lilemo tse 5 ho isa ho 11 e ne e tšoana le ea batho ba lilemo li 16 ho isa ho tse 25. Phuputsong eo, ente e ne e sebetsa ka 90.7% ho thibela COVID-19 ho bana ba lilemo tse 5 ho isa ho tse 11.

• Polokeho: Polokeho ya ente e hlahlobilwe ho bana ba ka bang 3,100 ba dilemo tse 5 ho ya ho 11 ba fumaneng ente mme ha ho ditlamorao tse mpe tse fumanweng thutong e ntseng e tswela pele.

• Komiti ea Boeletsi ea Litsi tsa Taolo le Thibelo ea Mafu (CDC) mabapi le Litloaelo tsa Ente e tla kopana bekeng e tlang ho buisana ka likhothaletso tse ling tsa bongaka.

“Joaloka ’mè le ngaka, kea tseba hore batsoali, bahlokomeli, basebetsi ba sekolo le bana ba ’nile ba emela tumello ea kajeno. Ho enta bana ba banyenyane khahlanong le COVID-19 ho tla re atametsa ho khutlela boemong bo tloaelehileng," ho boletse Mokhomishenara oa FDA Janet Woodcock, MD "Tekolo ea rona e felletseng le e matla ea datha e mabapi le polokeho le katleho ea ente e lokela ho thusa ho tiisetsa batsoali le bahlokomeli. hore ente ena e finyella litekanyetso tsa rōna tse phahameng.”

Ente ea Pfizer-BioNTech COVID-19 bakeng sa bana ba lilemo tse 5 ho isa ho tse 11 e fanoa e le letoto la mantlha la litekanyetso tse peli, li arohane ka libeke tse 3, empa ke tekanyetso e tlase (10 micrograms) ho feta e sebelisoang ho batho ba lilemo li 12 ho ea holimo. (30 micrograms).

Naheng ea Amerika, linyeoe tsa COVID-19 ho bana ba lilemo tse 5 ho isa ho tse 11 li etsa 39% ea linyeoe ho batho ba ka tlase ho lilemo tse 18. Ho latela CDC, linyeoe tse ka bang 8,300 tsa COVID-19 ho bana ba lilemo tse 5 ho isa ho tse 11 li bakile ho kena sepetlele. Ho tloha ka la 17 Mphalane, batho ba 691 ba bolailoe ke COVID-19 ho tlalehiloe US ho batho ba ka tlase ho lilemo tse 18, mme ba 146 ba shoele sehlopheng sa lilemo tse 5 ho isa ho tse 11.

"FDA e ikemiselitse ho etsa liqeto tse tataisoang ke saense tseo sechaba le sechaba sa tlhokomelo ea bophelo se ka li tšepang. Re na le ts'epo mabapi le polokeho, katleho le data ea tlhahiso ka mor'a tumello ena. E le karolo ea boitlamo ba rona ba ponaletso mabapi le liqeto tsa rona, tse neng li kenyelletsa kopano ea komiti ea boeletsi ba sechaba pejana bekeng ena, re kentse litokomane kajeno tse tšehetsang qeto ea rona le tlhaiso-leseling e eketsehileng e hlalosang tlhahlobo ea rona ea data haufinyane. Re tšepa hore boitsebiso bona bo thusa ho haha kholiseho ea batsoali ba etsang qeto ea hore na bana ba bona ba ka entoa,” ho boletse Peter Marks, MD, Ph.D., motsamaisi oa Setsi sa FDA sa Tlhahlobo le Lipatlisiso tsa Biologics.

FDA e entse qeto ea hore ente ena ea Pfizer e fihletse litekanyetso tsa tumello ea tšebeliso ea tšohanyetso. Ho ipapisitsoe le kakaretso ea bopaki ba mahlale bo fumanehang, melemo e tsebahalang le e ka bang teng ea ente ea Pfizer-BioNTech COVID-19 ho batho ba lilemo tse ka tlase ho tse 5 e feta likotsi tse tsejoang le tse ka bang teng.

SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:

Ente ea Pfizer-BioNTech COVID-19 bakeng sa bana ba lilemo tse 5 ho isa ho tse 11 e fanoa e le letoto la mantlha la litekanyetso tse peli, li arohane ka libeke tse 3, empa ke tekanyetso e tlase (10 micrograms) ho feta e sebelisoang ho batho ba lilemo li 12 ho ea holimo. (30 micrograms).
Based on the totality of scientific evidence available, the known and potential benefits of the Pfizer-BioNTech COVID-19 vaccine in individuals down to 5 years of age outweigh the known and potential risks.
The vaccine’s safety was studied in approximately 3,100 children age 5 through 11 who received the vaccine and no serious side effects have been detected in the ongoing study.